SERUM IGE CONCENTRATIONS, DISEASE-ACTIVITY, AND ATOPIC DISORDERS IN SYSTEMIC LUPUS-ERYTHEMATOSUS

被引:0
|
作者
ELKAYAM, O
TAMIR, R
PICK, AI
WYSENBEEK, A
机构
[1] BEILINSON MED CTR,DIV ALLERGY & CLIN IMMUNOL,IL-49100 TEL AVIV,ISRAEL
[2] BEILINSON MED CTR,RHEUMATOL UNIT,IL-49100 TEL AVIV,ISRAEL
[3] TEL AVIV UNIV,SACKLER FAC MED,IL-69978 TEL AVIV,ISRAEL
关键词
ATOPY; HYPERSENSITIVITY; IGE; NEPHRITIS; SLE PATHOGENESIS;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
We investigated the relationship between disease activity and total IgE concentration in the sera of patients with active systemic lupus erythematosus (SLE). In addition, the prevalence of personal and family history of allergic rhinitis and asthma were examined with a questionnaire and immediate skin tests for common inhalant allergens in 24 patients in remission. In the 20 patients with active disease, we found that IgE concentration was significantly higher during the periods of active disease than the periods of remission. This elevation was not associated with an elevation in total serum IgG concentrations. The increase in IgE concentration during disease activity in patients with active nephritis was significantly higher than in patients without nephritis. Of the 24 patients in remission, only one reported allergic rhinitis, and two had positive skin tests for inhalant allergens. We concluded that, although patients with SLE do not have an increased rate of atopic disorders, serum IgE rises during disease activity and is associated with active nephritis. This phenomenon suggests that IgE may be involved in the pathogenesis of SLE, particularly in patients with nephritis.
引用
收藏
页码:94 / 96
页数:3
相关论文
共 50 条
  • [21] LOW AVIDITY ANTIBODY AND DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    MCGRATH, H
    ZELMAN, D
    BIUNDO, JJ
    CLINICAL RESEARCH, 1983, 31 (02): : A652 - A652
  • [22] ANTIBODIES TO SM IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - CORRELATION WITH DISEASE-ACTIVITY
    BARADA, FA
    ANDREWS, BS
    DAVIS, JS
    ARTHRITIS AND RHEUMATISM, 1980, 23 (06): : 652 - 652
  • [23] CARDIAC ABNORMALITIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - PREVALENCE AND RELATIONSHIP TO DISEASE-ACTIVITY
    ONG, ML
    VEERAPEN, K
    CHAMBERS, JB
    LIM, MN
    MANIVASAGAR, M
    WANG, F
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1992, 34 (01) : 69 - 74
  • [24] CORRELATIONS OF GLOBAL MEASURES OF DISEASE-ACTIVITY AND TREATMENT IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    FORTIN, PR
    WRIGHT, EA
    LEW, RA
    FOSSEL, AH
    LIANG, MH
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S365 - S365
  • [25] THE CONTRIBUTION OF DISEASE-ACTIVITY TO COGNITIVE DEFICIT IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    CARBOTTE, RM
    DENBURG, S
    LONG, A
    SINGER, J
    DENBURG, J
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 1987, 9 (01) : 64 - 64
  • [26] A RELIABILITY STUDY OF SLEDAI - A DISEASE-ACTIVITY INDEX FOR SYSTEMIC LUPUS-ERYTHEMATOSUS
    HAWKER, G
    GABRIEL, S
    BOMBARDIER, C
    GOLDSMITH, C
    CARON, D
    GLADMAN, D
    JOURNAL OF RHEUMATOLOGY, 1993, 20 (04) : 657 - 660
  • [27] HEALTH-STATUS, DISEASE-ACTIVITY AND SEVERITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    DESSEIN, PH
    KING, PA
    STANWIX, AE
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S185 - S185
  • [28] DIRECT STIMULATION OF NEUTROPHIL OXYGENATION ACTIVITY BY SERUM FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - A RELATIONSHIP TO DISEASE-ACTIVITY
    VIA, CS
    ALLEN, RC
    WELTON, RC
    JOURNAL OF RHEUMATOLOGY, 1984, 11 (06) : 745 - 753
  • [29] SOLUBLE INTERLEUKIN-2 RECEPTOR AS A PARAMETER FOR DISEASE-ACTIVITY IN THE SERUM OF SYSTEMIC AND DISCOID LUPUS-ERYTHEMATOSUS
    BLUM, C
    ZILLIKENS, D
    TONY, HP
    HARTMANN, AA
    BURG, G
    HAUTARZT, 1993, 44 (05): : 290 - 295
  • [30] THE VALUE OF SERUM LAMININ-P1 IN MONITORING DISEASE-ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    SCHNEIDER, M
    HENGST, K
    WALDENDORF, M
    HOGEMANN, B
    GERLACH, U
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1988, 17 (05) : 417 - 422